EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure

T Herremans, J H Reimerink, T G Kimman, H G van Der Avoort, M P Koopmans

Clinical Diagnostic Laboratory Immunology · 2000-01 · 7 (1) · 40-44

DOI: 10.1128/cdli.7.1.40-44.2000 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Diagnostic Laboratory Immunology, 2000-01. Verfasst von T Herremans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Tineke.Herre…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Three important antigenic sites involved in virus neutralization on polioviruses in mouse experiments have been identified. These sites are located at the surface of the virion and have been designated antigenic sites 1, 2, and 3. In mice, the antibody response to antigenic site 1 of serotype 3 poliovirus is considered to be immunodominant, but little is known about the immunogenicity of these sites in humans. In the present study, we developed inhibition enzyme-linked immunosorbent assays specific for antigenic sites 1 and 3 to measure antibody responses to these sites in fully vaccinated inactivated poliovirus vaccine (IPV) ( n = 63) and oral live attenuated poliovirus vaccine (OPV) ( n = 63) recipients and in naturally infected persons ( n = 25). Similar levels of antibodies to site 1 in IPV and OPV vaccinees were detected. However, significantly more OPV recipients (88.7%) had detectable antibodies to antigenic site 3 ( P < 0.01) than did IPV-vaccinated persons (63.1%). After an IPV booster vaccination, both previously IPV- and OPV-vaccinated persons responded with a significant increase in antibodies to sites 1 and 3 ( P < 0.01). We conclude that the immune response to serotype 3 poliovirus in humans consists of both site 1- and site 3-specific antibodies and that these responses can be induced by either OPV or recent IPV vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAntibodies, ViralAntibody SpecificityAntigens, ViralChildEnzyme-Linked Immunosorbent AssayHumansImmunization, SecondaryPoliovirusPoliovirus Vaccine, OralSerotypingVaccines, AttenuatedVaccines, Inactivated

Substanzen

Antibodies, MonoclonalAntibodies, ViralAntigens, ViralPoliovirus Vaccine, OralVaccines, AttenuatedVaccines, Inactivated

Autor:innen und Institutionen

  • Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Tineke.Herremans@rivm.nl

Zitieren

APA

Herremans, T., Reimerink, J. H., Kimman, T. G., van Der Avoort, H. G., & Koopmans, M. P. (2000). Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure. Clinical Diagnostic Laboratory Immunology, 7(1), 40-44. https://doi.org/10.1128/cdli.7.1.40-44.2000

Vancouver

Herremans T, Reimerink JH, Kimman TG, van Der Avoort HG, Koopmans MP. Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure. Clinical Diagnostic Laboratory Immunology. 2000;7(1):40-44. doi:10.1128/cdli.7.1.40-44.2000

BibTeX
@article{Herremans2000,
  author = {Herremans, T and Reimerink, J H and Kimman, T G and van Der Avoort, H G and Koopmans, M P},
  title = {Antibody Responses to Antigenic Sites 1 and 3 of Serotype 3 Poliovirus after Vaccination with Oral Live Attenuated or Inactivated Poliovirus Vaccine and after Natural Exposure},
  journal = {Clinical Diagnostic Laboratory Immunology},
  year = {2000},
  volume = {7},
  number = {1},
  pages = {40--44},
  doi = {10.1128/cdli.7.1.40-44.2000}
}
Kostenlos starten →